Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like New SoCal Biotech Makes Debut and Will Take on NASH February 14, 2017 Repros Therapeutics Reports Second Quarter 2017 Financial Results August 13, 2017 Seattle Genetics Commences Dosing in Early-Stage Multiple Myeloma Trial March 6, 2018
